Literature DB >> 25565189

Diabetic nephropathy research in China: Data analysis and review from the National Natural Science Foundation of China.

Qiang Wan1, Yanying Xu, Erdan Dong.   

Abstract

As the largest funding agency of natural science of China, the National Natural Science Foundation of China (NSFC) has made great efforts in promoting the development of diabetic nephropathy (DN) research in recent years. The aim of the current study is to summarize the diabetic nephropathy research in China by analyzing NSFC-funded projects. Data on all projects in the DN field funded by NSFC from 1986 to 2013 were collected. The funding tendency, funding areas, and hotspots in the DN field, and major research institutions, were analyzed. As one output of this support, outstanding research groups in China, and their representative studies, are also highlighted. From 1986 to 2013, the NSFC has funded a total of 248 projects in the DN field, with a total funding amount of 91.5 million RMB (US$14.9 million). A rapid increase could be seen in the past 5 years, with an average annual 30% increase in projects numbers and a 52% increase in funding amount. All fields in DN research have been covered by the NSFC, including etiology, pathophysiology, diagnostics, and therapeutics. Along with increased funding of the DN research, there has been a growth in the papers published in Science Citation Index journals by Chinese scholars. In the past decade, the funding scale and funding budget have increased dramatically. Benefiting from this, DN research in China has also made considerable progression.
© 2015 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  National Natural Science Foundation of China funding profile; diabetic nephropathy; 关键词:糖尿病肾病,国家自然科学基金。

Mesh:

Year:  2015        PMID: 25565189     DOI: 10.1111/1753-0407.12265

Source DB:  PubMed          Journal:  J Diabetes        ISSN: 1753-0407            Impact factor:   4.006


  9 in total

Review 1.  Association between PAI-1 4G/5G polymorphism and diabetic nephropathy: a meta-analysis in the Chinese population.

Authors:  Wen-Feng Gao; Ying-Bo Guo; Yu Bai; Xin-Yu Ding; Yong-Ji Yan; Zhen-Qi Wu
Journal:  Int Urol Nephrol       Date:  2016-06-06       Impact factor: 2.370

2.  [Screening active ingredients of Shenkangwan that regulate endothelial-mesenchymal transition of endothelial cells in vitro].

Authors:  Cha Zhang; Jia-Xing Zhang; Yi-Fan Xiong; Lu Lu; Ming-Qing Wang; Si-Ming Liu; Wei Xiao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-03-20

Review 3.  Clinical Efficacy of Jinshuibao Capsules Combined with Angiotensin Receptor Blockers in Patients with Early Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Qiang Lu; Cailan Li; Weiwen Chen; Zhongfeng Shi; Ruoting Zhan; Rui He
Journal:  Evid Based Complement Alternat Med       Date:  2018-04-24       Impact factor: 2.629

4.  Interdisciplinarity research based on NSFC-sponsored projects: A case study of mathematics in Chinese universities.

Authors:  Zhi-Yi Shao; Yong-Ming Li; Fen Hui; Yang Zheng; Ying-Jie Guo
Journal:  PLoS One       Date:  2018-07-31       Impact factor: 3.240

5.  The role of serum and urinary biomarkers in the diagnosis of early diabetic nephropathy in patients with type 2 diabetes.

Authors:  Deyuan Zhang; Shandong Ye; Tianrong Pan
Journal:  PeerJ       Date:  2019-06-11       Impact factor: 2.984

6.  Global Research Trends on Prostate Diseases and Erectile Dysfunction: A Bibliometric and Visualized Study.

Authors:  Chengquan Ma; Hao Su; Hongjun Li
Journal:  Front Oncol       Date:  2021-02-12       Impact factor: 6.244

7.  Global Research Trends on the Treatment of Diffuse Large B-Cell Lymphoma: A Bibliometric and Visualized Study.

Authors:  Qintong Duan; Yufeng Li; Lijia Ou; Yajun Li; Ruolan Zeng; Yizi He; Tao Pan; Siwei Chen; Huan Chen; Hui Zang; Hui Zhou; Ling Xiao
Journal:  J Cancer       Date:  2022-03-14       Impact factor: 4.207

8.  The application of sudoscan for screening microvascular complications in patients with type 2 diabetes.

Authors:  Kun Lin; Yixi Wu; Shuo Liu; Jiaqi Huang; Guishan Chen; Qiong Zeng
Journal:  PeerJ       Date:  2022-03-14       Impact factor: 2.984

9.  How Does National Scientific Funding Support Emerging Interdisciplinary Research: A Comparison Study of Big Data Research in the US and China.

Authors:  Ying Huang; Yi Zhang; Jan Youtie; Alan L Porter; Xuefeng Wang
Journal:  PLoS One       Date:  2016-05-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.